Richard Anderson, Elsie Inglis Professor of Clinical Reproductive Science at the University of Edinburgh, is an outstanding clinical scientist and world leader in fertility and its preservation. He first identified the potential for measurement of anti-Mullerian hormone to assess ovarian toxicity from cancer treatment, now routine clinical practice world-wide in oncology trials in women. His exceptional level of expertise is sought after internationally as well as making a substantial NHS contribution providing Reproductive Endocrinology/ Infertility services.
A globally recognised international leader in the field of fertility preservation, he drives forward pioneering work in this field, promoting its recognition as a core component of cancer care and thereby improving lives of patients.